AbbVie Botox Therapeutic (onabotulinumtoxinA) by Year

Name: AbbVie Botox Therapeutic (onabotulinumtoxinA) by Year (ABBV)
Creator: AbbVie

Botox Therapeutic (onabotulinumtoxinA) — Worldwide net revenues ($M) ($M)

Quarterly Annual

AbbVie Botox Therapeutic (onabotulinumtoxinA): $3,769M in FY2025, up 14.8% from a year earlier. That is the highest of the 8 years on record here.

Latest, FY2025

3,769

Period ended Dec 31, 2025

Change on a year earlier

+14.8%

3,283 in FY2024

History

8 years

Since FY2018

Sources

Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-20) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Botox Therapeutic (onabotulinumtoxinA) — Worldwide net revenues ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	3,769	+14.8%	Form 10-K (filed 2026-02-20) ↗
FY2024	Dec 31, 2024	3,283	+9.8%	Form 10-K (filed 2026-02-20) ↗
FY2023	Dec 31, 2023	2,991	+10.0%	Form 10-K (filed 2026-02-20) ↗
FY2022	Dec 31, 2022	2,719	+10.9%	Form 10-K (filed 2025-02-14) ↗
FY2021	Dec 31, 2021	2,451	+76.7%	Form 10-K (filed 2024-02-20) ↗
FY2020	Dec 31, 2020	1,387	–	Form 10-K (filed 2023-02-17) ↗
FY2019	Dec 31, 2019	0	–	Form 10-K (filed 2022-02-18) ↗
FY2018	Dec 31, 2018	0	–	Form 10-K (filed 2021-02-19) ↗

Breakdown

What makes up botox Therapeutic (onabotulinumtoxinA)

Cite this data

StockData. (2026). AbbVie Botox Therapeutic (onabotulinumtoxinA) ($M), annual FY2018–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/botox-ther-ww

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.